Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Fever
Interventions: Masimo Temperature device; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 1 Year and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Orange, California

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions: Docetaxel, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration; Drug · Other
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older · Female only
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 482
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 309 more

Conditions: Healthy Subjects, Chronic Conditions, Multiple
Interventions: Neteera 130H; Device
Lead sponsor: Neteera Technologies Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Millcreek, Utah

Conditions: Lymphoma, Diabetes Mellitus, Type 2, Hyperglycemia
Interventions: Insulin protocol; Biological
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Smoking
Interventions: Augmented Reality 1, Augmented Reality 2, Augmented Reality 3, Augmented Reality 4; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 197 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Hypoxemia, Desaturation of Blood
Interventions: RespirAct Step-Wise Normocapnia desaturation sequence, RespirAct Slope Normocapnia desaturation sequence, RespirAct Step-Wise Hypocapnia desaturation sequence, RespirAct Slope Hypocapnia desaturation sequence, ROBD Step-Wise desaturation sequence; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: SARS-CoV2 Infection
Interventions: Rapid Antigen Screening Test; Device
Lead sponsor: Columbia University; Other
Eligibility: 2 Years and older
Enrollment: 337 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Epilepsy, Seizures, Seizures, Focal, Seizure, Refractory
Interventions: EpiCare@Home, wearable multimodal seizure monitoring system; Device
Lead sponsor: Byteflies; Industry
Eligibility: 12 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Arrhythmia
Interventions: Kardia 12L; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Syncope
Interventions: Comprehensive ED syncope/presyncope management tool; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 16 Years and older
Enrollment: 4,000 participants
Timeline: 2022 – 2024
U.S. locations: 5
States / cities: Oakland, California • Richmond, California • Roseville, California + 1 more

Conditions: Type 2 Diabetes
Interventions: Blood Draw; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Duarte, California

Conditions: Atopic Dermatitis
Interventions: Wrist Actigraphy Device, Sleep Headband; Device
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Orlando, Florida • Grayslake, Illinois • Rochester, New York

Conditions: Insulin Resistance, Diabetes
Interventions: Quantose IR and Quantose IGT analysis, HOMA IR the standard testing for insulin resistance; Diagnostic Test
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Chronic Ankle Instability, CAI, Ankle Sprain, Healthy
Interventions: Cobra Ankle Arthrometer; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 40 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Blood Pressure
Interventions: Collecting blood pressure measurements with noninvasive blood pressure device; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Atrial Fibrillation
Interventions: Single lead ambulatory ECG patch; Diagnostic Test
Lead sponsor: Fitbit LLC; Industry
Eligibility: 22 Years and older
Enrollment: 450,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: San Francisco, California • Boston, Massachusetts

Conditions: Autism Spectrum Disorder
Interventions: Cognoa ASD diagnostic device; Diagnostic Test
Lead sponsor: Cognoa, Inc.; Industry
Eligibility: 18 Months to 72 Months
Enrollment: 711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 16
States / cities: Scottsdale, Arizona • Laguna Niguel, California • Los Angeles, California + 8 more

Conditions: Lung Cancers
Interventions: Not listed
Lead sponsor: Everest Detection, Inc.; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Anemia, Healthy, Pediatric ALL
Interventions: Rad-67 Pulse oximeter; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 1 Month and older
Enrollment: 447 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 7
States / cities: Burbank, California • Irvine, California • Lake Forest, California + 3 more

Conditions: Nutritional Assessment
Interventions: Validation of the PortionSize app; Device
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 7 Years to 12 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Sleep Disorders, Circadian Rhythm, Circadian Rhythm Disorders, Circadian Rhythm Sleep Disorder, Advanced Sleep Phase Syndrome (ASPS), Delayed Sleep Phase Syndrome, Sleep Wake Disorders, Sleep Disorder
Interventions: dim light melatonin onset (DLMO); Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dialysis
Interventions: Algorithm model-based Aranesp doses, Standard of care; Procedure
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Murray, Utah

Conditions: Chest Pain
Interventions: Not listed
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 385 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Major Depressive Disorder, Mood Disorders, Mental Health Issue
Interventions: Wearing Samsung smartwatch and filling out daily surveys; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Calibration and Validation of the Masimo Temperature Device in Febrile Patients

Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

Heart Rate and Respiratory Rate Measurements by a Novel, Radar-based Device

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Utilizing Augmented Reality as an Adjunct for Smoking Cessation

Alternate Methodology of Pulse Oximeter Validation

COVID-19 SARS-CoV-2 RAST Study

EpiCare@Home Validation Study for Focal Onset Seizures

Clinical Validation of the AliveCor Kardia 12L and 6L Devices

Improving Management of Emergency Department Patients With Undifferentiated Syncope: Prospective Validation of the Canadian Syncope Risk Score

Validation of an RLIP76 Assay in Humans

A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)

Validation of a Novel Screening Test for Maternal Insulin Resistance

Validation of a Portable Ankle Arthrometer

Data Collection for Validation of an NIBP Algorithm in Pregnant Women

Validation of Software for Assessment of Atrial Fibrillation From PPG Data Acquired by a Wearable Smartwatch

Cognoa ASD Diagnosis Aid Validation Study

Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers

Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation

Validity of the PortionSize App to Measure Children's Food Intake

Validation of Circadian Biomarkers in Patients With Sleep Disorders

Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model

Validation of the Siemens System Somatom Definition and Operating Software for Cardiac CT Studies

Clinical Validation of Samsung Smartwatch